Inovio Pharmaceuticals, Inc.
INO
$1.64
-$0.04-2.39%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 119.43% | -80.79% | 27.04% | 35.36% | 22.48% |
| Total Depreciation and Amortization | -2.80% | -2.12% | -10.49% | -2.13% | 342.81% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -6,040.89% | 13,070.10% | 31.62% | -274.80% | -149.27% |
| Change in Net Operating Assets | -421.04% | 74.46% | -94.69% | -460.79% | 65.37% |
| Cash from Operations | 1.49% | 21.39% | 26.23% | 6.56% | 25.16% |
| Capital Expenditure | -- | -- | 93.17% | -66.85% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -60.01% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -99.80% | -36.53% | -49.00% | -99.98% | 74.72% |
| Cash from Investing | -100.17% | -37.01% | -47.00% | -100.11% | 73.71% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 107.43% | 1,089.82% | -100.00% | -78.91% | 611.61% |
| Repurchase of Common Stock | -- | 71.88% | 85.51% | 57.41% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -- | -- | -- | -- |
| Cash from Financing | -6.90% | 3,672.68% | -100.11% | 109.05% | 1,485.45% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -82.54% | 196.15% | -205.23% | -589.47% | 1,081.95% |